Loading...

Global Carbon Capture And Decarbonization Will Empower Industrial Transformation

Published
08 Apr 25
Updated
12 Apr 26
Views
190
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
48.7%
7D
-10.8%

Author's Valuation

AU$2.0571.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 12 Apr 26

CXL: Index Addition And Profit Outlook Will Support Future Upside

Analysts have slightly adjusted their price target for Calix, now seeing fair value at A$2.05. This reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, while leaving the overall valuation essentially unchanged.

What's in the News

  • Calix Limited (ASX:CXL) has been added to the S&P/ASX All Ordinaries Index. This may increase visibility among index funds and benchmark focused investors (Index Constituent Adds, S&P/ASX All Ordinaries Index).

Valuation Changes

  • Fair Value: A$2.05 is unchanged, indicating the updated assumptions have not altered the overall valuation outcome.
  • Discount Rate: has fallen slightly from 7.18% to 7.13%, a small adjustment to the risk and return assumptions used in the model.
  • Revenue Growth: has been kept effectively steady at about 25.33%, showing no material change in projected A$ revenue expansion assumptions.
  • Net Profit Margin: has nudged slightly higher from about 7.64% to 7.64%, reflecting a minor refinement in expected profitability levels.
  • Future P/E: has eased marginally from about 118.07x to 117.89x, a small shift in the earnings multiple applied to future projections.
5 viewsusers have viewed this narrative update

Key Takeaways

  • Regulatory support, new contracts, and strong recurring revenues position Calix for stable long-term growth and market expansion in industrial decarbonization technologies.
  • Completed investment cycle and cost reductions set the stage for higher profitability, while R&D focus aligns with global demand for low-carbon, flexible solutions.
  • Heavy dependence on a single revenue source, delayed project funding, and policy uncertainties threaten diversification, commercialization efforts, and future earnings stability.

Catalysts

About Calix
    An environmental technology company, provides industrial solutions to address global decarbonisation and sustainability challenges in Australia, Europe, the United States, and Southeast Asia.
What are the underlying business or industry changes driving this perspective?
  • Global regulatory momentum and increased government funding for industrial decarbonization-especially in Europe, Asia, and Australia-are set to accelerate adoption of Calix's carbon capture and green processing technologies, providing long-term revenue growth opportunities.
  • Expansion and strong performance in the magnesia (water) business, with new contracts in both Australia and the US and investments in production capacity, support a resilient, high-margin recurring revenue stream that is expected to underpin earnings and cash flow stability.
  • Commercial validation and new funding awards for major projects in lithium, iron & steel, and cement (including the lithium midstream JV and ZESTY demonstration plant), indicate increasing market traction and de-risking, which should lift forward earnings potential as these projects scale and transition to royalty/license models.
  • Aggressive cost base reductions and the completion of a heavy investment cycle have set the stage for improved operating leverage and net margin expansion, positioning Calix for higher profitability as revenue continues to increase.
  • Ongoing investments in R&D and technology that enable energy flexibility (switching between fossil fuels and renewables) align with global industry trends toward electrification and low-carbon production, expanding the company's addressable market and supporting sustainable top-line growth.
Calix Earnings and Revenue Growth

Calix Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Calix's revenue will grow by 25.3% annually over the next 3 years.
  • Analysts are not forecasting that Calix will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Calix's profit margin will increase from -159.8% to the average AU Chemicals industry of 7.6% in 3 years.
  • If Calix's profit margin were to converge on the industry average, you could expect earnings to reach A$4.7 million (and earnings per share of A$0.02) by about April 2029, up from -A$49.5 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 118.0x on those 2029 earnings, up from -3.0x today. This future PE is greater than the current PE for the AU Chemicals industry at 40.3x.
  • Analysts expect the number of shares outstanding to grow by 0.4% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.13%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Prolonged weakness and volatility in capital markets, especially within the cleantech sector, have made it difficult for Calix to secure necessary sub-level or project funding for major commercialization stages (e.g., ZESTY and Zeta). This funding constraint could impede technology scale-up, delay project delivery, and limit future revenue growth, putting pressure on the company's long-term earnings outlook.
  • Significant dependence on magnesia for current revenues (~85% of total revenue), while the high-potential lines (iron & steel, cement & lime, lithium) are still largely pre-commercial and reliant on achieving demonstration milestones and securing external capital; failure to diversify revenue sources may constrain revenue growth and lead to significant earnings volatility.
  • Ongoing permitting and grant disbursement delays, especially for large-scale projects (e.g., Leilac-2 plant in Europe, U.S. DOE grant) due to administrative or macro-political factors, create uncertainty in project timelines. Persistent delays may stall growth initiatives, push back cost synergies, and negatively affect revenue recognition and cash flow.
  • Market timing risk surrounding end-user demand (especially for lithium projects), with the company's near-term lithium revenue (e.g., from the Pilbara JV) highly sensitive to commodity price cycles; if lithium prices do not recover to historical averages, Calix may be forced to defer commissioning and revenue generation, impacting top-line growth and net margins.
  • Increasing reliance on public funding (government grants, match funding requirements) exposes Calix to policy and regulatory risk; changes in administration, funding priorities (e.g., in the U.S.), or environmental regulations can disrupt the expected inflow of funds, hinder commercialization, and thus adversely affect medium
  • and long-term revenue projections and profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of A$2.05 for Calix based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of A$2.4, and the most bearish reporting a price target of just A$1.7.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be A$61.0 million, earnings will come to A$4.7 million, and it would be trading on a PE ratio of 118.0x, assuming you use a discount rate of 7.1%.
  • Given the current share price of A$0.68, the analyst price target of A$2.05 is 66.8% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Calix?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

AU$1.7
FV
65.9% undervalued intrinsic discount
15
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative